Vector Science and Therapeutics Corp. (TSXV:PAIN)
Canada · Delayed Price · Currency is CAD 1.970
0.00 (0.00%)
Nov 3, 2026, 12:53 PM EST
Vector Science and Therapeutics Company Description
Vector Science and Therapeutics Corp. develops precision biomechanical devices and active transdermal delivery systems for musculoskeletal regeneration.
The company offers cGMP-manufactured Rx peptides for physicians and patients across sports, regenerative, and longevity medicine channels.
It also provides VectorMist, a commercial precision therapeutic platform, as well as Valor, a delivery system and transdermal platform.
The company is based in Mequon, Wisconsin.
Vector Science and Therapeutics Corp.
| Country | Canada |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | William Jackson |
Contact Details
Address: 12250 Corporate Parkway Mequon, Wisconsin 53092 United States | |
| Phone | (833) 832-8724 |
| Website | vectorscience.co |
Stock Details
| Ticker Symbol | PAIN |
| Exchange | TSX Venture Exchange |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| ISIN Number | CA92244M1041 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Barry Hix | Co-Founder, Chief Commercial Officer and Director |
| Stephen Gledhill CPA | Chief Financial Officer and Corporate Secretary |
| Thomas Bachinski | Chief Technology Officer |
| Dr. W. Bradley Worthington | Chief Medical Officer |
| Darryl Drake Jr. | President of Valor and Chairman of the Athletic Board |
| William Dexter Fowler | Chief Athletic Officer for Valor |